Bio-Combination 21 (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the Bio-Combination 21 drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: CALCAREA PHOSPHORICA, FERRUM PHOSPHORICUM, NATRUM MURIATICUM
SUBSTANCE NAME: TRIBASIC CALCIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; SODIUM CHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-04-05
END MARKETING DATE: 0000-00-00


Bio-Combination 21 HUMAN OTC DRUG Details:

Item DescriptionBio-Combination 21 from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 12; 3([hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2016-04-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-2376_07c79d5e-5065-46f3-a1c4-c6504404aa93
PRODUCT NDC: 15631-2376
APPLICATION NUMBER:

Other TRIBASIC CALCIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncBio-Combination 21